ImmunityBio, Inc.

Investigation Alert IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Johnson Fistel, LLP is investigating potential claims on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) against certain of its officers and directors.

If you are a current, long-term shareholder of ImmunityBio, continuously holding shares since May 23, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can submit your information below to join this action:

Recently a class action complaint was filed against the company. The filed complaint alleges that defendants made false statements and/or concealed that: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, Good Manufacturing Practice (“GMP”) deficiencies at its third-party contract manufacturing organizations (“CMOs”) for the antibody cytokine fusion protein N-803, commercially referred to as “Anktiva”; (ii) one or more of the Company’s third-party CMOs for Anktiva did in fact suffer from GMP deficiencies; (iii) the foregoing deficiencies was likely to cause the FDA to reject the Anktiva Biologics License Application (“BLA”) in its present form; (iv) accordingly, the Company overstated the regulatory approval prospects for the Anktiva BLA; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:
Johnson Fistel, LLP

501 W. Broadway, Suite 800, San Diego, CA 92101

James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471

jimb@johnsonfistel.com or fjohnson@johnsonfistel.com